Related references
Note: Only part of the references are listed.Mutant PfCRT Can Mediate Piperaquine Resistance in African Plasmodium falciparum With Reduced Fitness and Increased Susceptibility to Other Antimalarials
Kathryn J. Wicht et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study
Mallika Imwong et al.
LANCET INFECTIOUS DISEASES (2020)
Global Spread of Mutant PfCRT and Its Pleiotropic Impact on Plasmodium falciparum Multidrug Resistance and Fitness
Satish K. Dhingra et al.
MBIO (2019)
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
Leila S. Ross et al.
NATURE COMMUNICATIONS (2018)
Emergence of Plasmodium falciparum triple mutant in Cambodia
Gabriele Rossi et al.
LANCET INFECTIOUS DISEASES (2017)
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2017)
Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations
Valentine Duru et al.
BMC MEDICINE (2015)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frederic Ariey et al.
NATURE (2014)
In Silico Screening on the Three-dimensional Model of the Plasmodium vivax SUB1 Protease Leads to the Validation of a Novel Anti-parasite Compound
Anthony Bouillon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2013)
Plasmodium falciparum pfmdr1 Amplification, Mefloquine Resistance, and Parasite Fitness
Piyanuch Preechapornkul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Share Paper
